CN112841536A - Novel natto polypeptide health food and preparation method thereof - Google Patents
Novel natto polypeptide health food and preparation method thereof Download PDFInfo
- Publication number
- CN112841536A CN112841536A CN202110136782.1A CN202110136782A CN112841536A CN 112841536 A CN112841536 A CN 112841536A CN 202110136782 A CN202110136782 A CN 202110136782A CN 112841536 A CN112841536 A CN 112841536A
- Authority
- CN
- China
- Prior art keywords
- materials
- natto
- powder
- health food
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 56
- 235000013557 nattō Nutrition 0.000 title claims abstract description 45
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 29
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 25
- 235000013402 health food Nutrition 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims description 16
- 239000000463 material Substances 0.000 claims abstract description 54
- 239000000843 powder Substances 0.000 claims abstract description 47
- 244000068988 Glycine max Species 0.000 claims abstract description 29
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 29
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 27
- 239000011669 selenium Substances 0.000 claims abstract description 27
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims description 22
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 238000007873 sieving Methods 0.000 claims description 14
- 238000005303 weighing Methods 0.000 claims description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 10
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 10
- 239000000811 xylitol Substances 0.000 claims description 10
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 10
- 235000010447 xylitol Nutrition 0.000 claims description 10
- 229960002675 xylitol Drugs 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 230000033001 locomotion Effects 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229940057948 magnesium stearate Drugs 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- 229940086319 nattokinase Drugs 0.000 claims description 7
- 108010073682 nattokinase Proteins 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 7
- 229960001866 silicon dioxide Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000036772 blood pressure Effects 0.000 abstract description 8
- 241000282414 Homo sapiens Species 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 6
- 208000007536 Thrombosis Diseases 0.000 abstract description 4
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 230000001766 physiological effect Effects 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 229940091258 selenium supplement Drugs 0.000 description 24
- 235000013305 food Nutrition 0.000 description 8
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a novel natto polypeptide health food which comprises the following components in parts by weight: 40-50% of black natto powder, 15-25% of cordyceps militaris, 8-12% of soybean peptide powder, 2-4% of selenium-enriched yeast and the balance of auxiliary materials. The natto is added, so that the blood pressure can be adjusted bidirectionally, old thrombus and plaque can be dissolved, the blood fat can be adjusted, the fatigue can be eliminated, and the immunity of a human body can be improved comprehensively; by adding the soybean peptide powder, the soybean peptide powder contains various bioactive peptides, and has various physiological activities, such as antioxidation, blood pressure reduction, cholesterol reduction, blood fat reduction, fatigue resistance, immunity enhancement and the like.
Description
Technical Field
The invention relates to the technical field of health products, in particular to a novel natto polypeptide health food and a preparation method thereof.
Background
Cardiovascular and cerebrovascular diseases, thrombus and other diseases are the most serious and common diseases which seriously threaten the health of human beings, particularly middle-aged and elderly people. Particularly common diseases of middle-aged and elderly people over 50 years old are healthy, and have the characteristics of high morbidity, high disability rate and high mortality, even if the most advanced and perfect treatment means are applied at present, more than 50 percent of cerebral vascular accident survivors can not completely take care of themselves, the number of people dying from cardiovascular and cerebrovascular diseases every year in the world is as high as 1500 thousands of people, and the people live at the first of various causes of death. China has a large population, the aging speed of the population is accelerated, along with the rapid development of economy, the cardiovascular burden of people is increased due to the surplus of nutrition, the morbidity and the mortality of cardiovascular and cerebrovascular diseases of people are increased continuously, the number of people dying from the cardiovascular and cerebrovascular diseases every year in the world is as high as 1500 thousands of people, and the people live at the first position of various causes of death.
Aiming at the problem, the invention provides a novel natto polypeptide health food capable of reducing the occurrence of cardiovascular and cerebrovascular diseases, thrombus and other diseases and a preparation method thereof.
Disclosure of Invention
The invention aims to solve the technical problem of providing a novel natto polypeptide health food and a preparation method thereof, so as to solve the problems in the background technology.
In order to solve the technical problems, the technical scheme of the invention is as follows: a novel natto polypeptide health food comprises the following components in parts by weight: 40-50% of black natto powder, 15-25% of cordyceps militaris, 8-12% of soybean peptide powder, 2-4% of selenium-enriched yeast and the balance of auxiliary materials.
Preferably, the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
Preferably, the composition comprises the following components in parts by weight: 50% of black natto powder, 20% of cordyceps militaris, 10% of soybean peptide powder, 2% of selenium-enriched yeast and the balance of auxiliary materials.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
By adopting the technical scheme, the method has the following beneficial effects:
mixing semen Sojae Atricolor powder, Cordyceps militaris, soybean peptide powder, selenium-enriched yeast and some adjuvants, adding into three-dimensional motion mixer, mixing, and making into granule, tablet or capsule, adding semen Sojae Preparatum to regulate blood pressure, dissolve old thrombi plaque, regulate blood lipid, eliminate fatigue, and improve immunity; by adding the soybean peptide powder, the soybean peptide powder contains various bioactive peptides, and has various physiological activities, such as antioxidation, blood pressure reduction, cholesterol reduction, blood fat reduction, fatigue resistance, immunity enhancement and the like.
Detailed Description
The following further describes the embodiments of the present invention. It should be noted that the description of the embodiments is provided to help understanding of the present invention, but the present invention is not limited thereto. In addition, the technical features involved in the embodiments of the present invention described below may be combined with each other as long as they do not conflict with each other.
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
In view of this, the invention provides a novel natto polypeptide health food and a specific embodiment of a preparation method of the novel natto polypeptide health food.
Natto, originated in ancient China, is a bean product prepared by fermenting soybeans through bacillus subtilis, has viscosity, smells smelly and tastes slightly sweet, not only retains the nutritional value of soybeans, is rich in vitamin K2 and improves the digestibility of protein, but also generates various physiological active substances in the fermentation process, and has the health-care effects of dissolving fibrin in a body and regulating physiological functions. The health-care food is rich in various nutrients, can prevent intestinal diseases such as constipation and diarrhea, improve bone density and osteoporosis, can regulate blood pressure in two directions, dissolve old thrombus plaques, regulate blood fat, eliminate fatigue and comprehensively improve human immunity when being frequently eaten.
The soybean peptide powder is produced by using soybean meal or soybean protein as main raw materials and adopting an enzymolysis or microbial fermentation method, has a relative molecular mass of below 5000, and mainly comprises powdery substances of peptides. Compared with the original protein and amino acid preparation with the same components, the soybean peptide powder is easier to be absorbed by human body, can directly enter small intestine to be absorbed without gastrointestinal digestion, and is not influenced by physical condition. The soybean peptide powder contains various bioactive peptides, and has various physiological activities including resisting oxidation, lowering blood pressure, lowering cholesterol, reducing blood lipid, relieving fatigue, and enhancing immunity. As a novel multifunctional nutritional ingredient, the soybean peptide powder can be widely used in health food, infant food, sports food, fermented products, clinical nutritional preparations and the like.
The cordyceps militaris is called cordyceps militaris and cordyceps militaris, and the efficacy of the cordyceps militaris is as follows: the cordyceps militaris has the effects of tonifying lung yin and kidney yang, and treating kidney deficiency, impotence, spermatorrhea, soreness and pain of waist and knees and weakness after illness, and the traditional Chinese medicine considers that the cordyceps militaris plays a role in strengthening body resistance and consolidating body constitution, has obvious curative effects on senile chronic bronchitis and pulmonary heart disease, can improve the detoxifying capability of the liver, plays a role in protecting the liver, and improves the antiviral and anti-radiation capability of the body.
The traditional Chinese medicine considers that the cordyceps sinensis enters the lung and kidney two channels, can tonify lung yin and kidney yang, is mainly used for treating kidney deficiency, impotence and spermatorrhea, soreness and pain of waist and knees, weakness after illness, chronic cough and weakness, cough with phlegm and blood, spontaneous perspiration and night sweat and the like, and is the only traditional Chinese medicine capable of balancing and adjusting yin and yang simultaneously.
Proved by research, the cordyceps militaris has the functions of regulating the whole body function, improving the immunity, enhancing the phagocytic function of macrophages and promoting the formation of antibodies, and mainly has the functions of protecting the lung, tonifying the kidney, nourishing the liver, relieving cough and asthma, eliminating phlegm, moistening the skin, preventing wrinkles and aging, resisting bacteria and inflammation, calming, expanding blood vessels, reducing blood pressure, reducing blood sugar, resisting fatigue, resisting oxygen deficit and the like.
Selenium-enriched yeast is added with selenium element in the process of culturing yeast, and the selenium is absorbed and utilized during the growth of the yeast, so that the selenium is organically combined with protein and polysaccharide in the yeast body and converted into biological selenium, thereby eliminating the toxic and side reaction and the gastrointestinal stimulation of chemical selenium (such as sodium selenite) to a human body, and enabling the selenium to be absorbed and utilized by the human body more efficiently and more safely. The selenium-enriched yeast is the most efficient, safest and balanced nutritional selenium supplement preparation at home so far.
A novel natto polypeptide health food comprises the following components in parts by weight: 40-50% of black natto powder, 15-25% of cordyceps militaris, 8-12% of soybean peptide powder, 2-4% of selenium-enriched yeast and the balance of auxiliary materials.
Preferably, the auxiliary materials include rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate, and the auxiliary materials are not limited by specific components and can be added according to the needs of products.
Wherein, Polygonatum sibiricum Red is used for treating weakness of spleen and stomach, yin deficiency and lung dryness, dry cough with little phlegm, early white beard and hair, insufficiency of essence and blood, internal heat and diabetes, etc. Modern medical research shows that rhizoma polygonati also has the effects of reducing blood pressure, blood sugar and blood fat, preventing atherosclerosis, delaying senility and resisting bacteria, has a good curative effect on diabetes and has an inhibiting effect on various bacteria and dermatophytes.
The xylitol is used as a sweetener, a nutritional supplement and an auxiliary therapeutic agent for the diabetics: xylitol is an intermediate of carbohydrate metabolism of a human body, under the condition that insulin is lacked in the body to influence the carbohydrate metabolism, the xylitol can also penetrate through cell membranes without being promoted by the insulin, can be absorbed and utilized by tissues, promotes the synthesis of hepatic glycogen, provides nutrition and energy for cells, does not cause the increase of blood sugar value, and has the functions of improving the liver and preventing decayed teeth.
The microcrystalline cellulose is used as edible fiber and an ideal health food additive, can keep the stability of emulsification and foam, keep the stability at high temperature and improve the stability of liquid.
Magnesium stearate, C36H70MgO4, molecular weight 591.24, is an organic compound, is a white, non-gritty fine powder; slightly smelly; it has greasy feeling when contacting with skin. The product is insoluble in water, ethanol or diethyl ether, and can be used as lubricant, antisticking agent and glidant. Is especially suitable for granulating oil and extract medicines, and the prepared granules have good fluidity and compressibility. As a glidant in direct compression.
Preferably, the composition comprises the following components in parts by weight: 50% of black natto powder, 20% of cordyceps militaris, 10% of soybean peptide powder, 2% of selenium-enriched yeast and the balance of auxiliary materials.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
The technical solutions of the present invention are further described in detail with reference to the following specific examples, which should be understood as merely illustrative and not limitative.
Example 1
A novel natto polypeptide health food comprises the following components in parts by weight: 40% of black natto powder, 20% of cordyceps militaris, 10% of soybean peptide powder and 3% of selenium-enriched yeast, and the balance is auxiliary materials.
Preferably, the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
Example 2
A novel natto polypeptide health food comprises the following components in parts by weight: 44% of black natto powder, 17% of cordyceps militaris, 9% of soybean peptide powder and 3% of selenium-enriched yeast, and the balance is auxiliary materials.
Preferably, the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
Example 3
A novel natto polypeptide health food comprises the following components in parts by weight: 47% of black natto powder, 23% of cordyceps militaris, 8% of soybean peptide powder, 4% of selenium-enriched yeast and the balance of auxiliary materials.
Preferably, the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
Example 4
A novel natto polypeptide health food comprises the following components in parts by weight: 50% of black natto powder, 25% of cordyceps militaris, 8% of soybean peptide powder, 2% of selenium-enriched yeast and the balance of auxiliary materials.
Preferably, the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
In addition, the invention also provides a preparation method of the novel natto polypeptide health-care food, which comprises the following steps:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
Preferably, the mesh number in the step (2) is 60-100.
The embodiments of the present invention have been described in detail, but the present invention is not limited to the described embodiments. It will be apparent to those skilled in the art that various changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, and the scope of protection is still within the scope of the invention.
Claims (5)
1. A novel natto polypeptide health food is characterized by comprising the following components in parts by weight: 40-50% of black natto powder, 15-25% of cordyceps militaris, 8-12% of soybean peptide powder, 2-4% of selenium-enriched yeast and the balance of auxiliary materials.
2. The novel natto polypeptide health food according to claim 1, which is characterized in that: the auxiliary materials comprise rhizoma polygonati, microcrystalline cellulose, xylitol, maltodextrin, silicon dioxide and magnesium stearate.
3. The novel natto polypeptide health food as claimed in claim 1, which comprises the following components in parts by weight: 50% of black natto powder, 20% of cordyceps militaris, 10% of soybean peptide powder, 2% of selenium-enriched yeast and the balance of auxiliary materials.
4. A method for preparing a novel natto polypeptide health food according to any one of claims 1-3, comprising the steps of:
(1) selecting materials: selecting soybean peptide powder, cordyceps militaris, selenium-enriched yeast and black natto powder with nattokinase more than 2000 Fu/g;
(2) sieving: respectively sieving the materials selected in the step (1);
(3) preparing materials: weighing auxiliary materials and the sieved raw materials according to the formula ratio, and preparing for feeding;
(4) mixing materials: adding the raw materials prepared in the step (3) into a three-dimensional motion mixer, rotating and mixing for 20-30 minutes at the speed of 900r/min, taking out the mixed raw materials, and weighing for later use;
(5) and (3) granulating: and (3) putting the weighed mixture into a granulator to prepare granules, tablets or capsules.
5. The preparation method of the novel natto polypeptide health food as claimed in claim 4, wherein the mesh number in the step (2) is 60-100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110136782.1A CN112841536A (en) | 2021-02-01 | 2021-02-01 | Novel natto polypeptide health food and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110136782.1A CN112841536A (en) | 2021-02-01 | 2021-02-01 | Novel natto polypeptide health food and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112841536A true CN112841536A (en) | 2021-05-28 |
Family
ID=75987409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110136782.1A Pending CN112841536A (en) | 2021-02-01 | 2021-02-01 | Novel natto polypeptide health food and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112841536A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022580A (en) * | 1996-11-07 | 2000-02-08 | Keishi Nagashima | Natto food |
| CN104855845A (en) * | 2015-06-08 | 2015-08-26 | 周维官 | Natto nutritional health food |
| CN107348365A (en) * | 2017-08-18 | 2017-11-17 | 谢玲 | A kind of new natto polypeptide health care food |
| CN108065209A (en) * | 2016-11-14 | 2018-05-25 | 威海紫光生物科技开发有限公司 | A kind of adjusting blood fat and antifatigue health food |
| CN108783443A (en) * | 2018-06-21 | 2018-11-13 | 骆忠航 | A kind of tablet and preparation method thereof for internal organs conditioning |
| CN110214816A (en) * | 2019-07-11 | 2019-09-10 | 丁强 | A kind of natto polypeptide soymilk powder instant food and preparation method thereof |
| CN111280452A (en) * | 2018-12-06 | 2020-06-16 | 黄许仙 | Novel natto polypeptide health food |
-
2021
- 2021-02-01 CN CN202110136782.1A patent/CN112841536A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022580A (en) * | 1996-11-07 | 2000-02-08 | Keishi Nagashima | Natto food |
| CN104855845A (en) * | 2015-06-08 | 2015-08-26 | 周维官 | Natto nutritional health food |
| CN108065209A (en) * | 2016-11-14 | 2018-05-25 | 威海紫光生物科技开发有限公司 | A kind of adjusting blood fat and antifatigue health food |
| CN107348365A (en) * | 2017-08-18 | 2017-11-17 | 谢玲 | A kind of new natto polypeptide health care food |
| CN108783443A (en) * | 2018-06-21 | 2018-11-13 | 骆忠航 | A kind of tablet and preparation method thereof for internal organs conditioning |
| CN111280452A (en) * | 2018-12-06 | 2020-06-16 | 黄许仙 | Novel natto polypeptide health food |
| CN110214816A (en) * | 2019-07-11 | 2019-09-10 | 丁强 | A kind of natto polypeptide soymilk powder instant food and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105725008B (en) | A kind of composition and its preparation method and application of Bacillus subtilis natto fermentation Radix Astragali | |
| CN106072578A (en) | There is the enhancing enzyme composition of immune function of human body, effervescent tablet and preparation method | |
| CN113017092B (en) | Fermentation type small molecule peptide mixed solution for regulating blood sugar and preparation method and application thereof | |
| CN105360824B (en) | A kind of cordyceps drink and preparation method thereof | |
| CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
| CN108308488A (en) | Give birth to peptide solid beverage in the sources D- | |
| CN102293927B (en) | Compound Chinese medicinal preparation with antifatigue and antioxidation effects, and preparation method thereof | |
| CN109247571A (en) | A kind of anti-aging health preserving health-care food and preparation method thereof | |
| CN105707637A (en) | Solid beverage capable of reduce blood glucose, and preparation method thereof | |
| CN101884783B (en) | Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof | |
| CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
| CN107348365A (en) | A kind of new natto polypeptide health care food | |
| CN110604800A (en) | Alcohol-dispelling liver-protecting plant beverage for abstinence of alcohol and preparation method thereof | |
| CN110151983A (en) | A kind of Chinese materia medica preparation and preparation method thereof for tonifying Qi of the kidney | |
| CN109528953A (en) | There is a kind of pair of microcirculation in human body the grass that crosses of improvement result to collect Chinese medicine plant composition | |
| CN109275856A (en) | A kind of ganoderma lucidum food | |
| CN111467468A (en) | Concentrated nutrient solution containing ginseng, cordyceps militaris, ginger and wolfberry fruit and preparation method thereof | |
| CN104522572A (en) | Radix puerariae powder capable of supplementing qi and benefit spleen | |
| CN101190250B (en) | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof | |
| CN109757639A (en) | A kind of ginseng ternary peptide beverage and preparation method thereof | |
| CN112841536A (en) | Novel natto polypeptide health food and preparation method thereof | |
| KR100929880B1 (en) | Composition for stimulation for stimulating hair growth and preventing depilation containing leaves of thuja orientalis and preparing method thereof | |
| CN103976211A (en) | Slimming jelly and preparation method thereof | |
| CN111280452A (en) | Novel natto polypeptide health food | |
| CN114642236A (en) | Chlorella natto tablet candy capable of assisting in lowering blood pressure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |